Single-center evaluation of the single-dose pharmacokinetics of the angiotensin II receptor antagonist azilsartan medoxomil in renal impairment.
about
Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapySingle-dose pharmacokinetics and safety of azilsartan medoxomil in children and adolescents with hypertension as compared to healthy adults.Effects of Age, Sex, and Race on the Safety and Pharmacokinetics of Single and Multiple Doses of Azilsartan Medoxomil in Healthy SubjectsAzilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?Population Pharmacokinetics and Exposure-Response of a Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With Stage 2 Hypertension.Single-Center Evaluation of the Pharmacokinetics and Safety of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Mild to Moderate Hepatic Impairment.
P2860
Single-center evaluation of the single-dose pharmacokinetics of the angiotensin II receptor antagonist azilsartan medoxomil in renal impairment.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Single-center evaluation of th ...... medoxomil in renal impairment.
@en
Single-center evaluation of th ...... medoxomil in renal impairment.
@nl
type
label
Single-center evaluation of th ...... medoxomil in renal impairment.
@en
Single-center evaluation of th ...... medoxomil in renal impairment.
@nl
prefLabel
Single-center evaluation of th ...... medoxomil in renal impairment.
@en
Single-center evaluation of th ...... medoxomil in renal impairment.
@nl
P2093
P2860
P1476
Single-center evaluation of th ...... medoxomil in renal impairment
@en
P2093
Aziz Karim
Caroline Dudkowski
Domenic A Sica
Richard A Preston
P2860
P2888
P304
P356
10.1007/S40262-013-0044-Y
P50
P577
2013-05-01T00:00:00Z